FDA Inspection 1308330 — Thrombolex Inc
The FDA completed an inspection of Thrombolex Inc on March 13, 2026 in New Britain, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 13, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- New Britain, PA (United States)